This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Stocks Rising on Unusual Volume

Furiex Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Furiex Pharmaceuticals (FURX) is a drug development collaboration company. Furiex's product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. This stock is trading up 2.9% at $20.39 in recent trading.

Today's Volume: 149,000

Average Volume: 85,138

Volume % Change: 84%

Shares of FURX are ripping higher today ahead of the company's earnings report, which is set for Thursday after the market close.

From a technical perspective, FURX has started to move back above its 50-day moving average of $19.83 here with above average volume.

>>5 Biotech Stocks Poised for Breakouts

Traders should continue to look for long-biased trades in FURX ahead of its earnings report as long as it's trading above $19.83 with strong volume. I would consider any upside volume day that registers near or above 85,138 shares as bullish. After earnings, I would look for long-biased trades in FURX if it can manage to trigger a major breakout trade.

That trade will hit once FURX takes out some near-term overheard resistance at $22.47 with high volume. Look for a sustained move or close above $22.47 or Thursday's high (if it's greater) with volume that's near or above 85,138 shares. If we get that action, then look for FURX to hit $25 or higher post-earnings.
5 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
FURX $0.00 0.00%
CALL $6.05 -0.82%
CALM $52.35 0.89%
DNKN $46.50 0.56%
YNDX $20.15 -0.15%


Chart of I:DJI
DOW 17,659.14 -91.77 -0.52%
S&P 500 2,050.11 -13.26 -0.64%
NASDAQ 4,727.0990 -36.1250 -0.76%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs